SlideShare a Scribd company logo
The Pathologist and the breast biopsy report :
what about a synthetic table for invasive carcinoma?
Dr Elisabeth Russ
SENOPATH75
115, Rue du Château
75014 Paris
France
elisabeth.russ16@gmail.com
Genesis of the synthetic
table
• 2011 : original idea to transpose the pathology report table for
prostate biopsy to breast biopsy, especially for invasive
carcinomas
• Aim : to standardize the pathology reports of breast biopsy
contributory et representative nature of the biopsy
• Question : is the breast biopsy good enough for evaluation?
• contributory :
• Biopsy’s size
• Lenght of the invasive carcinoma focus (which paraffin block is informative?)
• representative : comparison between the lenght of the focus of invasive
carcinoma on the biopsy and the tumor size
• Is it the right grade?
• Are Hormone Receptors, Ki67 and HER2 good evaluated on the biopsy?
• Allways add a conclusion.
The table report
how many biopsies how many blocks
Biopsies’ size (mm)
Invasive carcinoma’s lenght : largest focus (mm) Informative paraffin block
Histological type of invasive carcinoma
architecture Well, moderate ou no differenciated (score)
anisokaryosis Mild to marked (score)
mitosis Number of mitosis/mm2 (score)
TIL (tumor infiltrating lymphocytes) %
Estrogen Receptors % of tumor cells intensity
Progesterone Receptors % of tumor cells intensity
Ki67 % of tumor cells
HER2 % of tumor cells Intensity et quality of the membrane staining
In situ carcinoma % nuclear grade, architecture
The table report : an example
Nombre de biopsiesno 22 Nombre de blocs : 2
Biopsies’ size (mm) 15/12
Invasive carcinoma’s lenght :
Largest focus (mm)
7 informative block : A
Histological type non specific type (NST)
architecture Moderate differenciated (score 2)
Anisokaryosis Moderate (score 2)
mitosis 2/mm2 (score 1)
TIL 10%
Estrogen Receptors 100% of tumor’s cells Intensity 3
Progesterone Receptors 100% of tumor’s cells Intensity 3
Ki67 10% of tumor’s cells
HER2 30% of tumor’s cells Weak incomplete membrane staining
Contingent de carcinome in situ 20% Intermediate nuclear grade
Cribriform architecture no necrosis, nor calcification
biopsies 2 2 blocks
Conclusion’s example
CONCLUSION :
• Invasive ductal carcinoma, moderate differenciated, non specific
type (NST)
• Histopronostic Index (E.E.) : 1 (2,2,1)
• Mitotic Index : mild
• TIL = 10%
• Hormone Receptors : strong positivity,
• Ki67 low
• Her2 negative (1+)
Value of pathology report tables in small cancers
T1a - T1b
• only scar or small foci of residual tumor after breast biopsy on
lumpectomy
• Especially after macro-biopsy
• All the informations are available on the pathology report table
of breast biopsy
Value of pathology report tables in large cancers
T2 - T3
• Neo-adjuvant chemotherapy
• If pCR : no residual tumor left on lumpectomy
• Very large size of the invasive carcinoma on biopsy is
necessary
• Macro-biopsy sometimes necessary.
Conclusion
• Pathology report table for breast biopsy can be helpfull
• Especially in invasive carcinomas
• Is the breast biopsy satisfactory enough to determine
histological grade and biomarkers (hormone receptors, Ki67
and HER2)?
• Small cancers T1a/T1b : only scar or small foci of residual
tumor after breast biopsy
• Large cancers T2/T3 : neo-adjuvant chemotherapy

More Related Content

Similar to BREAST CANCER : pathology report table for breast carcinomas

Osteosarcoma
OsteosarcomaOsteosarcoma
Osteosarcoma
Orthopedic for Life
 
ATA thyroid 2015
ATA thyroid 2015ATA thyroid 2015
ATA thyroid 2015
Warujpong Boonkum
 
Asnr
AsnrAsnr
Classification and staging of Lung Cancer.pptx
Classification and staging of Lung Cancer.pptxClassification and staging of Lung Cancer.pptx
Classification and staging of Lung Cancer.pptx
AkshaySarraf1
 
Surgical oncology
Surgical oncologySurgical oncology
Surgical oncology
Dr Ankur Shah
 
UME_HemOnc_CancerInstruction for resident 21112022.pptx
UME_HemOnc_CancerInstruction for resident 21112022.pptxUME_HemOnc_CancerInstruction for resident 21112022.pptx
UME_HemOnc_CancerInstruction for resident 21112022.pptx
MyThaoAiDoan
 
Adjuvant chemotherapy of breast cancer
Adjuvant chemotherapy of breast cancerAdjuvant chemotherapy of breast cancer
Adjuvant chemotherapy of breast cancer
Gita Bhat
 
Hipec _ meta analysis
Hipec  _ meta analysis Hipec  _ meta analysis
Hipec _ meta analysis
Kundan Singh
 
Breast cancer immune niche
Breast cancer immune nicheBreast cancer immune niche
Breast cancer immune niche
Lobna Shash
 
25987109 tipos-infrecuentes-de-cancer-de-mama
25987109 tipos-infrecuentes-de-cancer-de-mama25987109 tipos-infrecuentes-de-cancer-de-mama
25987109 tipos-infrecuentes-de-cancer-de-mama
Clinica de imagenes
 
Breast Cancer by dr Isa Basuki
Breast Cancer by dr Isa BasukiBreast Cancer by dr Isa Basuki
Breast Cancer by dr Isa Basuki
Isa Basuki
 
Cancer biology.ppt
Cancer biology.pptCancer biology.ppt
Cancer biology.ppt
TeshomeBacha1
 
Esophageal cancer practical target delineation 2013 may
Esophageal cancer practical target delineation 2013 mayEsophageal cancer practical target delineation 2013 may
Esophageal cancer practical target delineation 2013 may
Yong Chan Ahn
 
Case Study: Endometrial Cancer
Case Study: Endometrial CancerCase Study: Endometrial Cancer
Case Study: Endometrial Cancer
Ali Bagheri
 
Breast: Carcinoma in situ management
Breast: Carcinoma in situ management Breast: Carcinoma in situ management
Breast: Carcinoma in situ management
Isha Jaiswal
 
Circulating tumor cells in crc
Circulating tumor cells in crcCirculating tumor cells in crc
Circulating tumor cells in crc
Nilesh Kucha
 
approach for rectal carcinoma and management
approach for rectal carcinoma and managementapproach for rectal carcinoma and management
approach for rectal carcinoma and management
rajendra meena
 
Spinal Tumor.pptx
Spinal Tumor.pptxSpinal Tumor.pptx
Spinal Tumor.pptx
Reza Hambali
 
High risk early stage ec
High risk early stage ecHigh risk early stage ec
High risk early stage ec
Ashutosh Mukherji
 
Breast cancer- Current Concepts in Staging and Management
Breast cancer- Current Concepts in Staging and ManagementBreast cancer- Current Concepts in Staging and Management
Breast cancer- Current Concepts in Staging and Management
Sudeep Singh
 

Similar to BREAST CANCER : pathology report table for breast carcinomas (20)

Osteosarcoma
OsteosarcomaOsteosarcoma
Osteosarcoma
 
ATA thyroid 2015
ATA thyroid 2015ATA thyroid 2015
ATA thyroid 2015
 
Asnr
AsnrAsnr
Asnr
 
Classification and staging of Lung Cancer.pptx
Classification and staging of Lung Cancer.pptxClassification and staging of Lung Cancer.pptx
Classification and staging of Lung Cancer.pptx
 
Surgical oncology
Surgical oncologySurgical oncology
Surgical oncology
 
UME_HemOnc_CancerInstruction for resident 21112022.pptx
UME_HemOnc_CancerInstruction for resident 21112022.pptxUME_HemOnc_CancerInstruction for resident 21112022.pptx
UME_HemOnc_CancerInstruction for resident 21112022.pptx
 
Adjuvant chemotherapy of breast cancer
Adjuvant chemotherapy of breast cancerAdjuvant chemotherapy of breast cancer
Adjuvant chemotherapy of breast cancer
 
Hipec _ meta analysis
Hipec  _ meta analysis Hipec  _ meta analysis
Hipec _ meta analysis
 
Breast cancer immune niche
Breast cancer immune nicheBreast cancer immune niche
Breast cancer immune niche
 
25987109 tipos-infrecuentes-de-cancer-de-mama
25987109 tipos-infrecuentes-de-cancer-de-mama25987109 tipos-infrecuentes-de-cancer-de-mama
25987109 tipos-infrecuentes-de-cancer-de-mama
 
Breast Cancer by dr Isa Basuki
Breast Cancer by dr Isa BasukiBreast Cancer by dr Isa Basuki
Breast Cancer by dr Isa Basuki
 
Cancer biology.ppt
Cancer biology.pptCancer biology.ppt
Cancer biology.ppt
 
Esophageal cancer practical target delineation 2013 may
Esophageal cancer practical target delineation 2013 mayEsophageal cancer practical target delineation 2013 may
Esophageal cancer practical target delineation 2013 may
 
Case Study: Endometrial Cancer
Case Study: Endometrial CancerCase Study: Endometrial Cancer
Case Study: Endometrial Cancer
 
Breast: Carcinoma in situ management
Breast: Carcinoma in situ management Breast: Carcinoma in situ management
Breast: Carcinoma in situ management
 
Circulating tumor cells in crc
Circulating tumor cells in crcCirculating tumor cells in crc
Circulating tumor cells in crc
 
approach for rectal carcinoma and management
approach for rectal carcinoma and managementapproach for rectal carcinoma and management
approach for rectal carcinoma and management
 
Spinal Tumor.pptx
Spinal Tumor.pptxSpinal Tumor.pptx
Spinal Tumor.pptx
 
High risk early stage ec
High risk early stage ecHigh risk early stage ec
High risk early stage ec
 
Breast cancer- Current Concepts in Staging and Management
Breast cancer- Current Concepts in Staging and ManagementBreast cancer- Current Concepts in Staging and Management
Breast cancer- Current Concepts in Staging and Management
 

More from Elisabeth RUSS

Cancers du sein : nouvelle classification TNM - 8è édition / AJCC
Cancers du sein : nouvelle classification TNM - 8è édition / AJCCCancers du sein : nouvelle classification TNM - 8è édition / AJCC
Cancers du sein : nouvelle classification TNM - 8è édition / AJCC
Elisabeth RUSS
 
Breast Cancer : Le Pathologiste et les biopsies mammaires, utilité des tableaux
Breast Cancer : Le Pathologiste et les biopsies mammaires, utilité des tableauxBreast Cancer : Le Pathologiste et les biopsies mammaires, utilité des tableaux
Breast Cancer : Le Pathologiste et les biopsies mammaires, utilité des tableaux
Elisabeth RUSS
 
MICROCALCIFICATIONS ET NEOPLASIES LOBULAIRES
MICROCALCIFICATIONS ET NEOPLASIES LOBULAIRESMICROCALCIFICATIONS ET NEOPLASIES LOBULAIRES
MICROCALCIFICATIONS ET NEOPLASIES LOBULAIRES
Elisabeth RUSS
 
CANCERS MAMMAIRES : Interprétation et pertinence des prélèvements pré-opérato...
CANCERS MAMMAIRES : Interprétation et pertinence des prélèvements pré-opérato...CANCERS MAMMAIRES : Interprétation et pertinence des prélèvements pré-opérato...
CANCERS MAMMAIRES : Interprétation et pertinence des prélèvements pré-opérato...
Elisabeth RUSS
 
CANCERS MAMMAIRES : Peut-on présager de l’exactitude des résultats d’une bio...
 CANCERS MAMMAIRES : Peut-on présager de l’exactitude des résultats d’une bio... CANCERS MAMMAIRES : Peut-on présager de l’exactitude des résultats d’une bio...
CANCERS MAMMAIRES : Peut-on présager de l’exactitude des résultats d’une bio...
Elisabeth RUSS
 
CANCERS MAMMAIRES IN SITU : Quelles nouveautés dans les CLIS? REIMS 2014
CANCERS MAMMAIRES IN SITU : Quelles nouveautés dans les CLIS? REIMS 2014CANCERS MAMMAIRES IN SITU : Quelles nouveautés dans les CLIS? REIMS 2014
CANCERS MAMMAIRES IN SITU : Quelles nouveautés dans les CLIS? REIMS 2014
Elisabeth RUSS
 
Les cancers de l’endomètre : actualités 2016
Les cancers de l’endomètre : actualités 2016Les cancers de l’endomètre : actualités 2016
Les cancers de l’endomètre : actualités 2016
Elisabeth RUSS
 
CANCERS MAMMAIRES ET HER2 : LE ROLE CLE DU RADIOLOGUE DANS LE PRE-ANALYTIQUE
CANCERS MAMMAIRES ET HER2 : LE ROLE CLE DU RADIOLOGUE DANS LE PRE-ANALYTIQUECANCERS MAMMAIRES ET HER2 : LE ROLE CLE DU RADIOLOGUE DANS LE PRE-ANALYTIQUE
CANCERS MAMMAIRES ET HER2 : LE ROLE CLE DU RADIOLOGUE DANS LE PRE-ANALYTIQUE
Elisabeth RUSS
 
CARCINOMES MAMMAIRES : CYTOPONCTION GANGLIONNAIRE OU MICROBIOPSIE GANGLIONNAIRE?
CARCINOMES MAMMAIRES : CYTOPONCTION GANGLIONNAIRE OU MICROBIOPSIE GANGLIONNAIRE?CARCINOMES MAMMAIRES : CYTOPONCTION GANGLIONNAIRE OU MICROBIOPSIE GANGLIONNAIRE?
CARCINOMES MAMMAIRES : CYTOPONCTION GANGLIONNAIRE OU MICROBIOPSIE GANGLIONNAIRE?
Elisabeth RUSS
 
CARCINOMES MAMMAIRES INFRA-CENTIMETRIQUES : MICROBIOPSIES OU MACROBIOPSIES
CARCINOMES MAMMAIRES INFRA-CENTIMETRIQUES : MICROBIOPSIES OU MACROBIOPSIESCARCINOMES MAMMAIRES INFRA-CENTIMETRIQUES : MICROBIOPSIES OU MACROBIOPSIES
CARCINOMES MAMMAIRES INFRA-CENTIMETRIQUES : MICROBIOPSIES OU MACROBIOPSIES
Elisabeth RUSS
 
CARCINOMES MAMMAIRES INFILTRANTS : MICROBIOPSIES OU MACROBIOPSIES?
CARCINOMES MAMMAIRES INFILTRANTS : MICROBIOPSIES OU MACROBIOPSIES?CARCINOMES MAMMAIRES INFILTRANTS : MICROBIOPSIES OU MACROBIOPSIES?
CARCINOMES MAMMAIRES INFILTRANTS : MICROBIOPSIES OU MACROBIOPSIES?
Elisabeth RUSS
 
CANCERS MAMMAIRES ET COMPTES RENDUS FICHES STANDARDISES
CANCERS MAMMAIRES ET COMPTES RENDUS FICHES STANDARDISESCANCERS MAMMAIRES ET COMPTES RENDUS FICHES STANDARDISES
CANCERS MAMMAIRES ET COMPTES RENDUS FICHES STANDARDISES
Elisabeth RUSS
 
CANCERS MAMMAIRES INFRA-CENTIMETRIQUES
CANCERS MAMMAIRES INFRA-CENTIMETRIQUESCANCERS MAMMAIRES INFRA-CENTIMETRIQUES
CANCERS MAMMAIRES INFRA-CENTIMETRIQUES
Elisabeth RUSS
 
CLIS jfr2015.pdf%%
CLIS jfr2015.pdf%%CLIS jfr2015.pdf%%
CLIS jfr2015.pdf%%
Elisabeth RUSS
 
Cancer mammaire : les tumeurs infra-centimétriques
Cancer mammaire : les tumeurs infra-centimétriquesCancer mammaire : les tumeurs infra-centimétriques
Cancer mammaire : les tumeurs infra-centimétriques
Elisabeth RUSS
 
Actualité 2016 : les cancers de l’endometre
Actualité 2016 : les cancers de l’endometreActualité 2016 : les cancers de l’endometre
Actualité 2016 : les cancers de l’endometre
Elisabeth RUSS
 
Cancers mammaires : Impacts des recommandations du NCCN 2016
Cancers mammaires : Impacts des recommandations du NCCN 2016Cancers mammaires : Impacts des recommandations du NCCN 2016
Cancers mammaires : Impacts des recommandations du NCCN 2016
Elisabeth RUSS
 
Cancer mammaire : Le radiologue, HER2 & le pré-analytique.
Cancer mammaire : Le radiologue, HER2 & le pré-analytique.Cancer mammaire : Le radiologue, HER2 & le pré-analytique.
Cancer mammaire : Le radiologue, HER2 & le pré-analytique.
Elisabeth RUSS
 
Cancer mammaire : carcinomes lobulaires in situ.
Cancer mammaire : carcinomes lobulaires in situ. Cancer mammaire : carcinomes lobulaires in situ.
Cancer mammaire : carcinomes lobulaires in situ.
Elisabeth RUSS
 
Cancer mammaire - St Paul 2015 - Peut-on présager de l’exactitude des résulta...
Cancer mammaire - St Paul 2015 - Peut-on présager de l’exactitude des résulta...Cancer mammaire - St Paul 2015 - Peut-on présager de l’exactitude des résulta...
Cancer mammaire - St Paul 2015 - Peut-on présager de l’exactitude des résulta...
Elisabeth RUSS
 

More from Elisabeth RUSS (20)

Cancers du sein : nouvelle classification TNM - 8è édition / AJCC
Cancers du sein : nouvelle classification TNM - 8è édition / AJCCCancers du sein : nouvelle classification TNM - 8è édition / AJCC
Cancers du sein : nouvelle classification TNM - 8è édition / AJCC
 
Breast Cancer : Le Pathologiste et les biopsies mammaires, utilité des tableaux
Breast Cancer : Le Pathologiste et les biopsies mammaires, utilité des tableauxBreast Cancer : Le Pathologiste et les biopsies mammaires, utilité des tableaux
Breast Cancer : Le Pathologiste et les biopsies mammaires, utilité des tableaux
 
MICROCALCIFICATIONS ET NEOPLASIES LOBULAIRES
MICROCALCIFICATIONS ET NEOPLASIES LOBULAIRESMICROCALCIFICATIONS ET NEOPLASIES LOBULAIRES
MICROCALCIFICATIONS ET NEOPLASIES LOBULAIRES
 
CANCERS MAMMAIRES : Interprétation et pertinence des prélèvements pré-opérato...
CANCERS MAMMAIRES : Interprétation et pertinence des prélèvements pré-opérato...CANCERS MAMMAIRES : Interprétation et pertinence des prélèvements pré-opérato...
CANCERS MAMMAIRES : Interprétation et pertinence des prélèvements pré-opérato...
 
CANCERS MAMMAIRES : Peut-on présager de l’exactitude des résultats d’une bio...
 CANCERS MAMMAIRES : Peut-on présager de l’exactitude des résultats d’une bio... CANCERS MAMMAIRES : Peut-on présager de l’exactitude des résultats d’une bio...
CANCERS MAMMAIRES : Peut-on présager de l’exactitude des résultats d’une bio...
 
CANCERS MAMMAIRES IN SITU : Quelles nouveautés dans les CLIS? REIMS 2014
CANCERS MAMMAIRES IN SITU : Quelles nouveautés dans les CLIS? REIMS 2014CANCERS MAMMAIRES IN SITU : Quelles nouveautés dans les CLIS? REIMS 2014
CANCERS MAMMAIRES IN SITU : Quelles nouveautés dans les CLIS? REIMS 2014
 
Les cancers de l’endomètre : actualités 2016
Les cancers de l’endomètre : actualités 2016Les cancers de l’endomètre : actualités 2016
Les cancers de l’endomètre : actualités 2016
 
CANCERS MAMMAIRES ET HER2 : LE ROLE CLE DU RADIOLOGUE DANS LE PRE-ANALYTIQUE
CANCERS MAMMAIRES ET HER2 : LE ROLE CLE DU RADIOLOGUE DANS LE PRE-ANALYTIQUECANCERS MAMMAIRES ET HER2 : LE ROLE CLE DU RADIOLOGUE DANS LE PRE-ANALYTIQUE
CANCERS MAMMAIRES ET HER2 : LE ROLE CLE DU RADIOLOGUE DANS LE PRE-ANALYTIQUE
 
CARCINOMES MAMMAIRES : CYTOPONCTION GANGLIONNAIRE OU MICROBIOPSIE GANGLIONNAIRE?
CARCINOMES MAMMAIRES : CYTOPONCTION GANGLIONNAIRE OU MICROBIOPSIE GANGLIONNAIRE?CARCINOMES MAMMAIRES : CYTOPONCTION GANGLIONNAIRE OU MICROBIOPSIE GANGLIONNAIRE?
CARCINOMES MAMMAIRES : CYTOPONCTION GANGLIONNAIRE OU MICROBIOPSIE GANGLIONNAIRE?
 
CARCINOMES MAMMAIRES INFRA-CENTIMETRIQUES : MICROBIOPSIES OU MACROBIOPSIES
CARCINOMES MAMMAIRES INFRA-CENTIMETRIQUES : MICROBIOPSIES OU MACROBIOPSIESCARCINOMES MAMMAIRES INFRA-CENTIMETRIQUES : MICROBIOPSIES OU MACROBIOPSIES
CARCINOMES MAMMAIRES INFRA-CENTIMETRIQUES : MICROBIOPSIES OU MACROBIOPSIES
 
CARCINOMES MAMMAIRES INFILTRANTS : MICROBIOPSIES OU MACROBIOPSIES?
CARCINOMES MAMMAIRES INFILTRANTS : MICROBIOPSIES OU MACROBIOPSIES?CARCINOMES MAMMAIRES INFILTRANTS : MICROBIOPSIES OU MACROBIOPSIES?
CARCINOMES MAMMAIRES INFILTRANTS : MICROBIOPSIES OU MACROBIOPSIES?
 
CANCERS MAMMAIRES ET COMPTES RENDUS FICHES STANDARDISES
CANCERS MAMMAIRES ET COMPTES RENDUS FICHES STANDARDISESCANCERS MAMMAIRES ET COMPTES RENDUS FICHES STANDARDISES
CANCERS MAMMAIRES ET COMPTES RENDUS FICHES STANDARDISES
 
CANCERS MAMMAIRES INFRA-CENTIMETRIQUES
CANCERS MAMMAIRES INFRA-CENTIMETRIQUESCANCERS MAMMAIRES INFRA-CENTIMETRIQUES
CANCERS MAMMAIRES INFRA-CENTIMETRIQUES
 
CLIS jfr2015.pdf%%
CLIS jfr2015.pdf%%CLIS jfr2015.pdf%%
CLIS jfr2015.pdf%%
 
Cancer mammaire : les tumeurs infra-centimétriques
Cancer mammaire : les tumeurs infra-centimétriquesCancer mammaire : les tumeurs infra-centimétriques
Cancer mammaire : les tumeurs infra-centimétriques
 
Actualité 2016 : les cancers de l’endometre
Actualité 2016 : les cancers de l’endometreActualité 2016 : les cancers de l’endometre
Actualité 2016 : les cancers de l’endometre
 
Cancers mammaires : Impacts des recommandations du NCCN 2016
Cancers mammaires : Impacts des recommandations du NCCN 2016Cancers mammaires : Impacts des recommandations du NCCN 2016
Cancers mammaires : Impacts des recommandations du NCCN 2016
 
Cancer mammaire : Le radiologue, HER2 & le pré-analytique.
Cancer mammaire : Le radiologue, HER2 & le pré-analytique.Cancer mammaire : Le radiologue, HER2 & le pré-analytique.
Cancer mammaire : Le radiologue, HER2 & le pré-analytique.
 
Cancer mammaire : carcinomes lobulaires in situ.
Cancer mammaire : carcinomes lobulaires in situ. Cancer mammaire : carcinomes lobulaires in situ.
Cancer mammaire : carcinomes lobulaires in situ.
 
Cancer mammaire - St Paul 2015 - Peut-on présager de l’exactitude des résulta...
Cancer mammaire - St Paul 2015 - Peut-on présager de l’exactitude des résulta...Cancer mammaire - St Paul 2015 - Peut-on présager de l’exactitude des résulta...
Cancer mammaire - St Paul 2015 - Peut-on présager de l’exactitude des résulta...
 

Recently uploaded

Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
chandankumarsmartiso
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 

Recently uploaded (20)

Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 

BREAST CANCER : pathology report table for breast carcinomas

  • 1. The Pathologist and the breast biopsy report : what about a synthetic table for invasive carcinoma? Dr Elisabeth Russ SENOPATH75 115, Rue du Château 75014 Paris France elisabeth.russ16@gmail.com
  • 2. Genesis of the synthetic table • 2011 : original idea to transpose the pathology report table for prostate biopsy to breast biopsy, especially for invasive carcinomas • Aim : to standardize the pathology reports of breast biopsy
  • 3. contributory et representative nature of the biopsy • Question : is the breast biopsy good enough for evaluation? • contributory : • Biopsy’s size • Lenght of the invasive carcinoma focus (which paraffin block is informative?) • representative : comparison between the lenght of the focus of invasive carcinoma on the biopsy and the tumor size • Is it the right grade? • Are Hormone Receptors, Ki67 and HER2 good evaluated on the biopsy? • Allways add a conclusion.
  • 4. The table report how many biopsies how many blocks Biopsies’ size (mm) Invasive carcinoma’s lenght : largest focus (mm) Informative paraffin block Histological type of invasive carcinoma architecture Well, moderate ou no differenciated (score) anisokaryosis Mild to marked (score) mitosis Number of mitosis/mm2 (score) TIL (tumor infiltrating lymphocytes) % Estrogen Receptors % of tumor cells intensity Progesterone Receptors % of tumor cells intensity Ki67 % of tumor cells HER2 % of tumor cells Intensity et quality of the membrane staining In situ carcinoma % nuclear grade, architecture
  • 5. The table report : an example Nombre de biopsiesno 22 Nombre de blocs : 2 Biopsies’ size (mm) 15/12 Invasive carcinoma’s lenght : Largest focus (mm) 7 informative block : A Histological type non specific type (NST) architecture Moderate differenciated (score 2) Anisokaryosis Moderate (score 2) mitosis 2/mm2 (score 1) TIL 10% Estrogen Receptors 100% of tumor’s cells Intensity 3 Progesterone Receptors 100% of tumor’s cells Intensity 3 Ki67 10% of tumor’s cells HER2 30% of tumor’s cells Weak incomplete membrane staining Contingent de carcinome in situ 20% Intermediate nuclear grade Cribriform architecture no necrosis, nor calcification biopsies 2 2 blocks
  • 6. Conclusion’s example CONCLUSION : • Invasive ductal carcinoma, moderate differenciated, non specific type (NST) • Histopronostic Index (E.E.) : 1 (2,2,1) • Mitotic Index : mild • TIL = 10% • Hormone Receptors : strong positivity, • Ki67 low • Her2 negative (1+)
  • 7. Value of pathology report tables in small cancers T1a - T1b • only scar or small foci of residual tumor after breast biopsy on lumpectomy • Especially after macro-biopsy • All the informations are available on the pathology report table of breast biopsy
  • 8. Value of pathology report tables in large cancers T2 - T3 • Neo-adjuvant chemotherapy • If pCR : no residual tumor left on lumpectomy • Very large size of the invasive carcinoma on biopsy is necessary • Macro-biopsy sometimes necessary.
  • 9. Conclusion • Pathology report table for breast biopsy can be helpfull • Especially in invasive carcinomas • Is the breast biopsy satisfactory enough to determine histological grade and biomarkers (hormone receptors, Ki67 and HER2)? • Small cancers T1a/T1b : only scar or small foci of residual tumor after breast biopsy • Large cancers T2/T3 : neo-adjuvant chemotherapy